Market Overview

Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

Related UTHR
Mid-Morning Market Update: Markets Down; Ford Earnings Miss Views
Cowen: In Biotech Earnings We Trust
Biotechs Weaken, But These Names Have Bullish Charts (Investor's Business Daily)
Related ENDP
Watch Out Below, Endo International Investors, Management Is Doubling Down On Weak Assets
Benzinga's Top Downgrades
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2015 Update (Seeking Alpha)

Below are the top drug manufacturers-other stocks on the NASDAQ in terms of earnings estimate for the next year.

United Therapeutics (NASDAQ: UTHR) is likely to earn $6.96 per share in the next year ending December, 2014. United Therapeutics' trailing-twelve-month ROE is 24.83%.

Endo Health Solutions (NASDAQ: ENDP) may earn $3.83 per share in the next year ending December, 2014. Endo Health's trailing-twelve-month revenue is $3.03 billion.

The Medicines Company (NASDAQ: MDCO) is projected to earn $1.15 per share for the next year ending December, 2014. Medicines Company's trailing-twelve-month operating margin is 16.42%.

Cubist Pharmaceuticals (NASDAQ: CBST) is expected to earn $1.14 per share over the next year ending December, 2014. Cubist's trailing-twelve-month ROA is 2.54%.

Posted-In: Drug Manufacturers-Other Industry EPS Estimates NASDAQTrading Ideas


Related Articles (CBST + ENDP)

Get Benzinga's Newsletters